Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 11 of 11 entries
View as:

Phase 1 Study of ANAVEX3-71

Phase: N/A Priority: Normal
NCT ID: NCT04442945 Org: User:
Start: 07/03/20 End: 10/30/21 Due: 10/30/22

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02244541 Org: User:
Start: 12/31/14 End: 11/30/16 Due: 11/30/17

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03790709 Org: User:
Start: 07/03/18 End: 06/30/22 Due: 06/30/23

A Study of ANAVEX3-71 in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06245213 Org: User:
Start: 03/15/24 End: 06/30/25 Due: 06/30/26

ANAVEX2-73 Study in Patients With Rett Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03941444 Org: User:
Start: 05/06/19 End: 09/30/21 Due: 09/30/22

Study of ANAVEX2-73 in Patients With Rett Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03758924 Org: User:
Start: 02/28/19 End: 10/30/20 Due: 10/30/21

ANAVEX2-73 Study in Parkinson's Disease Dementia

Phase: N/A Priority: Normal
NCT ID: NCT03774459 Org: User:
Start: 07/09/18 End: 09/30/20 Due: 09/30/21

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04304482 Org: User:
Start: 07/01/20 End: 06/30/23 Due: 06/30/24

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02756858 Org: User:
Start: 03/31/16 End: 11/30/20 Due: 11/30/21

OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Phase: N/A Priority: Normal
NCT ID: NCT04314934 Org: User:
Start: 10/10/19 End: 06/14/24 Due: 06/14/25

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Phase: N/A Priority: Normal
NCT ID: NCT04575259 Org: User:
Start: 10/10/19 End: 06/30/22 Due: 06/30/23